Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children | Reuters

The Pfizer /BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday.
— Read on www.reuters.com/business/healthcare-pharmaceuticals/pfizerbiontech-covid-19-vaccine-shows-907-efficacy-trial-children-2021-10-22/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s